Khan A, Khan MZ, Dou J, Umer S, Xu H, Sammad A, Zhu HB, Wang Y
Understanding how retatrutide affects these outcomes will be every bit as important as documenting pounds lost
Rates vary from 6% in women in Germany to almost 20% in some clinics
Wegovy, approved in 2021, has shown significant results in promoting weight loss, with clinical trial participants losing an average of 17-18% of their body weight over 68 weeks
By offering Lipo B injections in a medical setting, Soboba Weight Loss gives local patients access to a treatment option that is part of a broader weight-loss framework rather than a standalone wellness trend
PMID: 28781108 (This report is OPEN ACCESS if you would like to read it) In the study, the investigators recruited 62 people with Parkinsons (average time since diagnosis was approximately 6 years) and they randomly assigned them to one of two groups, exenatide (the Bydureon formulation which is injected once per week) or placebo (32 and 30 people, respectively)